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S U M M A R Y
Objectives: Q fever has been reported throughout the African continent. The objective of this study was to
detect the presence of Coxiella burnetii in febrile patients from Africa.
Methods: Blood samples from febrile and non-febrile patients from six African countries and from France
were investigated retrospectively for Q fever infection by molecular assays targeting the IS1111 and
IS30A spacers.
Results: We tested 1888 febrile patients from Senegal, Mali, Tunisia, Algeria, Gabon, and Morocco and
found one male adult patient (0.3%) infected with C. burnetii in Algeria and six positive patients (0.5%) in
Senegal. For one patient from Senegal we determined that the infection was caused by C. burnetii
genotype 35. In Senegal, more patients were infected with C. burnetii in Keur Momar Sarr (p = 0.002) than
in the other locations. Blood samples taken from 500 (51% males) non-febrile people from Senegal and
France were all negative.
Conclusions: The installation of point-of-care laboratories in rural Africa can be a very effective tool for
studying the epidemiology of many infectious diseases.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Fever is a common problem for which patients seek medical
advice. Investigations of the spectrum of etiology of unknown fever
in Africa have progressed rapidly during recent years, resulting in
an improvement in knowledge about bacterial infection.1 Most
uninvestigated causes of death in Sub-Saharan Africa are the result
of infectious diseases.1 Moreover, travelers in Africa are exposed to
various health risks in unfamiliar environments, and fever is a
common problem in travelers.2–4 Most cases are acquired in Sub-
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in returnees with a systemic febrile illness.2,3 In 2008, we started to
investigate the causes of fever of unknown origin (FUO) in Africa,
and particularly in Senegal, to identify appropriate strategies for
case management in rural communities.5–8
Q fever is a worldwide zoonosis with many acute and chronic
manifestations that is caused by the pathogen Coxiella burnetii.9
Clinical ﬁndings in Q fever infection are often confusing, and
primary infection is asymptomatic in approximately 60% of cases.9
Infections with C. burnetii occur throughout Africa.10 In some cases
of Q fever, bacteria may persist for years despite antibiotic therapy,
and it has been proposed that in endemic regions, humans may
excrete C. burnetii, even without evident clinical signs, for a long
time.6 A high prevalence of Q fever was identiﬁed recently in
several villages in Senegal, indicating that Q fever should beciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
E. Angelakis et al. / International Journal of Infectious Diseases 28 (2014) 107–110108considered a signiﬁcant public health threat.6 Moreover, several
strains of C. burnetii have been isolated from soft ticks in Senegal.6
Although more than 40 tick species have been found infected with
C. burnetii, ticks are not considered essential in the natural cycle of
C. burnetii in livestock.9
To better guide diagnostic approaches and empirical therapies
in Africa, more studies are needed to assess the role of fastidious
bacterial infections in systemic febrile illness. The improvement in
molecular biology tools, especially the availability of full genome
sequences and real-time (RT)-PCR assays, has made it possible to
design speciﬁc and sensitive assays in a systematic strategic
approach to the diagnosis of Q fever. The objective of this study was
to detect the presence of C. burnetii infection in febrile populations
in Africa, an area in which epidemiological and clinical studies of
zoonoses are scarce, using molecular methods. We collected blood
samples from febrile and non-febrile patients from France and six
countries in North and Sub-Saharan Africa to investigate for C.
burnetii infection using molecular assays.
2. Materials and methods
2.1. Patients
Patients from six African countries with fever were investigated
retrospectively for Q fever infection (Figure 1). Health centers
distributed throughout six rural villages in Senegal were included
from June 2010 to March 2012. Patients were sampled in the
Kenitra region (dispensaries) of Morocco in 2008, and in Mali
(Diankabou, Kole) and Franceville, Gabon in 2011. Patients were
sampled in Sfax (infectious diseases and pediatric departments),
Tunisia, and in Oran (department of infectious diseases), Algeria in
2012. All patients from Senegal, Morocco, and Gabon originated
from rural areas, whereas the patients from Tunisia, Algeria, and
Mali originated from urban areas (Table 1). The study sites inFigure 1. Coxiella burnetii-positive cases at the different health centers includSenegal covered various ecosystems, from the dry area in the north
to the humid area in the south, with a rainy season from June
through October. As controls, blood samples from non-febrile
villagers in Senegal and from Marseille, France were tested.
Interviews, sampling, and a medical examination by physicians
were performed on each individual with fever (an axillary
temperature >37.5 8C).
2.2. Molecular diagnosis and multi-spacer sequence typing
A 200-ml sample of whole blood was collected in ethylenedia-
minetetraacetic acid (EDTA; Becton, Dickinson and Company,
USA). The samples were handled under sterile conditions to avoid
cross-contamination. DNA was extracted from the blood samples
from France, Senegal, Algeria, Tunisia, and Morocco using a
QIAamp kit (Qiagen, Hilden, Germany) in accordance with the
manufacturer’s instructions. For Gabon, DNA was extracted from
blood samples by DNA Blood Omega Bio-Tek E.Z.N.A method
(Omega Bio-Tek, USA) as per the manufacturer’s protocols. The
genomic DNA of each sample was stored at 20 8C under sterile
conditions. The genomic DNA of each sample was then sent to the
World Health Organization (WHO) Collaborative Center for
Rickettsial Diseases (Marseille) under sterile conditions at
20 8C. DNA was initially detected by C. burnetii-speciﬁc RT-PCR
with primers and probes designed for the ampliﬁcation of the
IS1111 and IS30A spacers.11 The quality of DNA handling and the
extraction of samples was veriﬁed by RT-PCR for a housekeeping
gene encoding the human beta-actin gene.6,12 A sample was
considered positive when PCR was positive for both IS1111 and
IS30A spacers. Results were considered negative when PCR for C.
burnetii was negative for both IS1111 and IS30A spacers and the
cycle threshold (Ct) value of the beta-actin control gene was
strongly positive 30 indicating an appropriate DNA load. DNA
extracts were also tested by RT-PCR for the presence of Tropherymaed in the current study (red color, rural areas; blue color, urban areas).
Table 1









Keur Momar Sarr S3 70 743 223 (43%) Sahelian/steppe-type Rural 5 (2.2%)
Niakhar S4 69 446 316 (45%) Sahelo-Sudanian/wooded steppe Rural 0
Casamance S5 57 505 411 (51%) Sub-Guinean/primary and secondary gallery forests Rural 0
Kedougou S6 20 021 288 (49%) Sudano-Guinean/woodland, wooded savannah Rural 1 (0.3%)
Mali Diankabou – Kole 14 833 100 (50%) Sahelian/savannas, forest Urban 0
Gabon Franceville 56 000 50 (46%) Equatorial/ savannah and tropical forest Rural 0
North Africa
Algeria Oran 1 584 607 268 (63%) Mediterranean climate Urban 1 (0.3%)
Morocco Kenitra 1 859 540 48 (27%) Mild Mediterranean climate Rural 0
Tunisia Sfax 2 256 320 184 (59%) Mediterranean climate Urban 0
Total 1888 (53%) 7
Non-febrile patients
Senegal
Dielmo S1 200 (53%) Sudanian/wooded savannah 0
Ndiop S2 200 (40%) Sudanian/wooded savannah 0
France Marseille 100 (71%) Mediterranean climate 0
Total 500 (51%) 0
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Staphylococcus aureus, Escherichia coli, and Plasmodium falci-
parum.13 Samples were also tested by 16S rRNA and 18S rRNA
gene ampliﬁcation and sequencing.13,14
We determined the multi-spacer sequence typing (MST)
genotypes of C. burnetii in the positive C. burnetii samples from
Senegal and Oran, as described previously.15
2.3. Statistical analysis
For data comparison, the Fisher’s exact test was performed
using EpiInfo version 6.0 software (Centers for Disease Control and
Prevention, Atlanta, GA, USA). A p-value of 0.05 was considered to
be signiﬁcant.
2.4. Ethics statement
This study was done after ethical approval was obtained from
the national ethics committees of Senegal, Gabon, and France (No.
0-00.87MSP/DS/CNERS and No. 001380MSP/DS/CNERS). Written
individual informed consent was obtained from each participant,
including the parents or legal guardians of all minors. For Morocco,
Algeria, Tunisia, and Mali our study design conformed to directives
concerning the conduct of clinical trials for these countries.
3. Results
Overall, we tested 1238 febrile patients from Senegal (50%
males), 100 from Mali (50% males), 50 from Gabon (46% males),
184 from Tunisia (59% males), 268 from Algeria (63% males), and
48 from Morocco (27% males) (Table 1). All patients were negativeTable 2
Patients with Coxiella burnetii infection
Patient Place Sex Age Season 
1 Keur Momar Sarr Male 10 Dry 
2 Keur Momar Sarr Male 12 Dry 
3 Keur Momar Sarr Male 15 Dry 
4 Keur Momar Sarr Male 56 Rainy 
5 Keur Momar Sarr Female 17 Dry 
6 Kedougou Female 1 Dry 
7 Oran Male 21 Summer-dry for the infectious agents tested except for C. burnetii, which was
found in six febrile patients (0.4%) in Senegal and in one (0.3%) in
Algeria (Table 2). We did not ﬁnd patients infected with C. burnetii
in Mali, Morocco, Gabon, or Tunisia. Four of the C. burnetii-positive
patients (66%) from Senegal were adolescents (<18 years old), one
was an adult male, and surprisingly, one was a 1-year-old child.
Fever and pulmonary manifestations were the most common
clinical manifestations in these patients (Table 2). Contact was lost
with these patients and none received doxycycline treatment. All
non-febrile people from Marseille and from Dielmo and Ndiop
were negative for C. burnetii.
In Keur Momar Sarr (Senegal), we tested 223 patients (43%
males) and found ﬁve febrile patients (2.2%; four males and one
female) infected with C. burnetii. Four cases occurred during the
dry season, whereas one case occurred during the rainy season. In
Kedougou, we tested 288 patients (49% males) and detected one
female patient (0.3%) infected with C. burnetii during the dry
season. Signiﬁcantly more patients were infected with C. burnetii in
Keur Momar Sarr than in the other locations in Senegal (p < 0.001).
Based on our data, we estimate that the incidence of C. burnetii-
positive cases was 480/100 000 febrile patients in Keur Momar
Sarr. However, we could not estimate the incidence of C. burnetii
for the other locations in Senegal.
In Oran, Algeria, we found one patient infected with C.
burnetii. The patient was a 21-year-old male with asthenia who
suffered from a persistent fever and myalgia for 6 days. The patient
had respiratory symptoms including cough, with radiographic
results compatible with atypical pneumonia at the time of sample
collection. Laboratory values revealed a white cell count of
9.6  109/l (73% lymphocytes) and increased aspartate amino-
transferase and alanine aminotransferase (66 and 104 U/l,Area Clinical manifestations Doxycycline treatment
Rural Fever No
Rural Fever No
Rural Persistent fever No
Rural Persistent fever and vomiting No
Rural Fever and cough No
Rural Pneumonia, vomiting No
Urban Persistent fever No
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for 3 days, and the fever resolved. However, contact was then lost
with the patient.
3.1. Multi-spacer sequence typing
Although seven MST genotyping studies were attempted, only
one genotype was determined; C. burnetii genotype 35 was
identiﬁed in one patient from Keur Momar Sarr. All attempts to
genotype the other positive samples were unsuccessful, possibly
because of low DNA load.
4. Discussion
In this study, we found that C. burnetii was the cause of fever in
six patients from Senegal and one from Algeria. We believe our
ﬁndings are reliable, because each positive result was conﬁrmed by
the ampliﬁcation of a second speciﬁc gene of C. burnetii to avoid
false-positive results.11,12 Although in Gabon the local laboratory
at the time of the study used a different DNA extraction assay than
the other laboratories, this did not have an impact on our assays
because the quality of DNA extraction was veriﬁed for all samples
and the analysis of all controls yielded expected results. Our
speciﬁc RT-PCR assay for the detection of C. burnetii was capable of
detecting 102 bacteria/ml.11 A limitation of our study was that the
diagnosis was based only on molecular and not on serological data.
Microimmunoﬂuorescence (IFA) is the reference technique for
diagnosing Q fever.16,17 However this was not performed because
IFA requires highly experienced technicians,9 and such expertise
was not available in the local laboratories that participated in this
study. As a result, in the absence of serological data, we could not
determine if our C. burnetii-positive patients were suffering from
acute Q fever or Q fever endocarditis.
We found C. burnetii genotype 35 in a patient from Senegal. This
genotype was recently found in ticks from Senegal,6 but this is the
ﬁrst time that this genotype has been detected in a human. In a
previous study, C. burnetii genotypes 6, 35, and 36 were identiﬁed
in ticks from Senegal.6 Moreover, C. burnetii genotype 19 was
detected previously in a patient with endocarditis from Senegal.6
In contrast, a larger biodiversity of strains has been observed in
samples from patients in metropolitan France, where 21 genotypes
circulate.15,18 However, in the recent Q fever outbreak in the
Netherlands, it appears that a single strain (genotype 33) was
responsible for the epidemic.19,20 Recently, a new C. burnetii
genotype (genotype 51) was identiﬁed in an aortic valve sample
from a patient with Q fever endocarditis in Saudi Arabia.21
In a previous study, a high seroprevalence of Q fever was found
in West, Central, and southern Africa.10 People in these rural areas
are owners of a high number of domestic ruminants, and C. burnetii
is also present in the household environment.22 In Senegal, a high
incidence rate was recently reported among people living in the
villages of Dielmo (73/100 000 person-years) and Ndiop (223/
100 000 person-years).22 In the present study, the incidence of
acute Q fever in Keur Momar Sarr was 480/100 000 febrile patients.
If the incidence of fever is comparable to that in the villages of
Dielmo and Ndiop, the current incidence may be 150/100 000
inhabitants. If our hypothesis is true, Senegal may be the country
with the highest Q fever incidence among the tested countries.
However, the fact that we tested fewer patients in Morocco, Mali,
Gabon, Tunisia, and Algeria and that patients in Tunisia, Mali, and
Algeria we primarily from urban areas could possibly explain why
we found only one C. burnetii-positive patient in all these countries.
The installation of point-of-care (POC) laboratories in rural
Senegal is a very effective tool for studying the epidemiology of
many infectious diseases.1,23 Molecular methods play a primary
role in the diagnosis of many infectious diseases, and thewidespread use of RT-PCR, which is less expensive than
conventional PCR, can reduce the delay in diagnosis of infections.
For this study, all blood samples were initially collected in the rural
health dispensaries and were then sent to our reference center in
Marseille for molecular analysis. As a result, a lot of time was lost in
obtaining the diagnosis and contact was lost with all the C. burnetii-
infected patients.
In conclusion, we showed that C. burnetii may be a cause of fever
primarily in children and young adolescents living in Senegal.
Patients living in rural areas of Africa or travelers returning from
these areas with unexplained fever should be tested for C. burnetii
infection. Molecular methods provide a convenient tool for the
diagnosis of C. burnetii, and as a result, we believe that the presence
of POC laboratories in rural areas of Africa is critical.
Funding: No funding sources declared.
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